Comparative efficacy of olfactory training versus combination therapy with oral corticosteroids in COVID-19 associated post-viral olfactory dysfunction
DOI:
https://doi.org/10.18203/issn.2454-5929.ijohns20262385Keywords:
Post-viral olfactory dysfunction, Olfactory training, Corticosteroids, Anosmia, COVID-19, Sniffin’ sticksAbstract
Background: Post-viral olfactory dysfunction (PVOD) has emerged as a critical public health concern, amplified exponentially by the COVID-19 pandemic. While olfactory training (OT) is the current gold standard for rehabilitation, the additive role of systemic corticosteroids remains controversial, particularly for patients presenting late. This study aimed to compare the efficacy of classical OT alone versus a combination of oral corticosteroids and OT in patients with persistent PVOD.
Methods: A prospective cohort study was conducted at the Department of Otorhinolaryngology in a tertiary care hospital in Mangalore between January 2021 and December 2023. We prospectively enrolled and analyzed 142 patients diagnosed with PVOD lasting >4 weeks. Group A received classical OT alone (n=72), and group B received a 14-day tapering course of oral corticosteroids combined with OT (n=70). Olfactory function was assessed using the "Sniffin’ sticks" test (TDI score) at baseline and 12 weeks post-treatment.
Results: Both groups showed significant improvement in TDI scores (p<0.001). Group A improved from a mean baseline TDI of 16.4±4.2 to 21.8±5.1. Group B improved from 15.9±3.8 to 24.1±4.9. Inter-group comparison revealed a statistically significant greater improvement in group B (Combination Therapy) compared to group A (OT alone) (p=0.03). Clinically significant improvement (increase in TDI ≥5.5) was observed in 34.7% of group A and 48.5% of group B.
Conclusions: While OT remains the cornerstone of therapy, a short course of oral corticosteroids in the persistent phase of PVOD offers significant synergistic benefits. This combination mitigates local neuroinflammation and yields superior olfactory recovery scores, even in sub-acute presentations.
References
Hummel T, Landis BN, Hüttenbrink KB. Smell and taste disorders. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2011;10:Doc04.
Stogbauer J, Wirkner K, Engel C, Moebus S, Pundt N, Teismann H, et al. Prevalence and risk factors of smell dysfunction-a comparison between five German population-based studies. Rhinology. 2020;58(2):184-91.
Seiden AM. Postviral olfactory loss. Otolaryngol Clin North Am. 2004;37(6):1159-66.
Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251-61.
Yan CH, Faraji F, Prajapati DP, Boone CE, DeConde AS. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol. 2020;10(7):806-13.
Vaira LA, Hopkins C, Salzano G, Petrocelli M, Melis A, Cucurullo M, et al. Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study. Head Neck. 2020;42(7):1560-9.
Bischoff S, Moyaert M, Clijsters M, Vanderbroek A, Van Gerven L. Treatment of COVID-19 Associated Olfactory Dysfunction: A Systematic Review. Curr Allergy Asthma Rep. 2024;25(1):2.
Bilinska K, Jakubowska P, Von Bartheld CS, Butowt R. Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age. ACS Chem Neurosci. 2020;11(11):1555-62.
Hopkins C, Surda P, Whitehead E, Kumar BN. Early recovery following new onset anosmia during the COVID-19 pandemic - an observational cohort study. J Otolaryngol Head Neck Surg. 2020;49(1):26.
Hummel T, Rissom K, Reden J, Hähner A, Weidenbecher M, Hüttenbrink KB. Effects of olfactory training in patients with olfactory loss. Laryngoscope. 2009;119(3):496-9.
Damm M, Pikart LK, Reimann H, Burkert S, Göktas Ö, Haxel B, et al. Olfactory training is helpful in postinfectious olfactory loss: a randomized, controlled, multicenter study. Laryngoscope. 2014;124(4):826-31.
Harless L, Liang J. Pharmacologic treatment for postviral olfactory dysfunction: a systematic review. Int Forum Allergy Rhinol. 2016;6(7):760-7.
Seo BS, Lee HJ, Mo JH, Lee CH, Rhee CS, Kim JW. Treatment of postviral olfactory loss with glucocorticoids, Ginkgo biloba, and mometasone nasal spray. Arch Otolaryngol Head Neck Surg. 2009;135(10):1000-4.
Kobal G, Hummel T, Sekinger B, Barz S, Roscher S, Wolf S. "Sniffin' sticks": screening of olfactory performance. Rhinology. 1996;34(4):222-6.
Thangaraj P, Varadharajan R. Assessment of Olfactory Dysfunction Using ODOFIN Sniffin' Sticks: A Prospective Comparative Study. Indian J Otolaryngol Head Neck Surg. 2023;75(1):1078-83.
Gudziol V, Lötsch J, Hähner A, Zahnert T, Hummel T. Clinical significance of results from olfactory testing. Laryngoscope. 2006;116(10):1858-63.
Kollndorfer K, Kowalczyk K, Hoche E, Mueller CA, Pollak M, Trattnig S, et al. Recovery of olfactory function induces neuroplasticity effects in patients with smell loss. Neural Plast. 2014;2014:140419.
Pendolino AL, Ottaviano G, Nijim J, Scarpa B, De Lucia G, Berro C, et al. A multicenter real-life study to determine the efficacy of corticosteroids and olfactory training in improving persistent COVID-19-related olfactory dysfunction. Laryngoscope Investig Otolaryngol. 2022;8(1):46-54.
Le Bon SD, Konopnicki D, Pisarski N, Prunier L, Lechien JR, Horoi M. Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell. Eur Arch Otorhinolaryngol. 2021;278(8):3113-7.
Tavares MVB, Mares GS, Danieluk MF, Godoy MDCL, Balasso RCA, Soares DF, et al. Olfactory Training and Oral Corticosteroid Therapy for Persistent Postinfectious Hyposmia. Int Arch Otorhinolaryngol. 2025;29(3):1-7.
Helman SN, Adler J, Jafari A, Bennett S, Vuncannon JR, Cozart AC, et al. Treatment strategies for postviral olfactory dysfunction: A systematic review. Allergy Asthma Proc. 2022;43(2):96-105.
Downloads
Published
How to Cite
Issue
Section
